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Macroautophagy, microautophagy, and chaperone-
mediated autophagy are conserved catabolic 
processes in eukaryotic cells that deliver cyto-
plasmic material to lysosomes (1). Macroau-
tophagy (hereafter referred to as autophagy) 
is uniquely defi   ned by the formation of 
  autophagosomes, double membrane vesicles 
0.5–1.5 μm in diameter arising through the 
elongation of a cup-shaped isolation mem-
brane around cellular cargo (1). A screen of yeast 
mutants incapable of surviving nitrogen starva-
tion has identifi  ed a network of Atg genes im-
portant for the formation of autophagosomes 
(2). Homologues of these genes have been 
identifi  ed and characterized in the mammalian 
system. Although autophagy has been long 
recognized, only recently have its essential 
roles in various cellular functions been estab-
lished (3, 4). For example, mice lacking the 
autophagy gene Atg5 or Atg7 cannot with-
stand short periods of starvation and display 
  severe neurodegenerative disease (5–7). Auto-
phagy is also essential for maintaining cell 
  survival after growth factor withdrawal (8). 
Furthermore, autophagy contributes to the 
clearance of intracellular pathogens includ-
ing group  A Streptococcus and Mycobacterium 
  tuberculosis (9, 10).
Autophagy is initiated through a well-con-
served molecular pathway. Class III phosphati-
dylinoside 3-kinase in complex with Beclin-1 
(yeast Atg6) induces autophagosome formation 
(11, 12). Two ubiquitin-like conjugation systems 
downstream of Beclin-1–phosphatidylinoside 
3-kinase are important for the induction of 
  autophagy. The terminal products of one of 
these two pathways, an Atg5–Atg12 covalent 
complex, is required for the elongation of the 
isolation membrane (13). The second pathway re-
sults in the conjugation of microtubule-associated 
protein 1 light chain 3 (LC3; yeast Atg8) to 
phospholipids for incorporation into the auto-
phagosome membrane (14).
Although autophagy is important for sur-
vival during periods of nutrient deprivation (5), 
its role in regulating cellular life and death deci-
sions remains largely unknown (for review see 
reference 15). The induction of autophagy may 
either program or prevent cell death (3, 4, 16). 
Regardless, the regulation of autophagy and 
apoptosis is likely to be linked at the mole-
cular level. The autophagy protein Beclin-1 
binds to antiapoptotic Bcl-2 family proteins, 
including Bcl-xL and Bcl-2 (17). Atg5 in-
teracts with Fas-associated via death domain 
(FADD), a death receptor adaptor protein (18). 
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Macroautophagy (hereafter referred to as autophagy) is a well-conserved intracellular 
degradation process. Recent studies examining cells lacking the autophagy genes Atg5 
and Atg7 have demonstrated that autophagy plays essential roles in cell survival during 
starvation, in innate cell clearance of microbial pathogens, and in neural cell maintenance. 
However, the role of autophagy in T lymphocyte development and survival is not known. 
Here, we demonstrate that autophagosomes form in primary mouse T lymphocytes. By genera-
ting Atg5−/− chimeric mice, we found that Atg5-defi  cient T lymphocytes underwent full 
maturation. However, the numbers of total thymocytes and peripheral T and B lymphocytes 
were reduced in Atg5 chimeras. In the periphery, Atg5−/− CD8+ T lymphocytes displayed 
dramatically increased cell death. Furthermore, Atg5−/− CD4+ and CD8+ T cells failed to 
undergo effi  cient proliferation after TCR stimulation. These results demonstrate a critical 
role for Atg5 in multiple aspects of lymphocyte development and function and suggest 
that autophagy may be essential for both T lymphocyte survival and proliferation.
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Autophagy-dependent death occurs in cells whose apoptotic 
machinery has been disabled (19, 20).
Although innate immune cells, such as macrophages, use 
autophagy to clear microbial pathogens, it is not known 
whether autophagy has a role in the adaptive immune system. 
Only recently has evidence emerged that T cells may be ca-
pable of inducing autophagy. Human T lymphocytes stimu-
lated and cultured in vitro form autophagosomes as identifi  ed 
by transmission electron microscopy (21). CD4+ human um-
bilical cord T cells also can be induced to form autophago-
somes by the HIV-1 envelope glycoprotein (22). Yet a role 
for autophagy in T cells remains undefi  ned.
To study the role of autophagy in T lymphocyte devel-
opment and function, we fi  rst assessed the induction of auto-
phagy in primary mouse T lymphocytes. We then generated 
autophagy-defi   cient lymphocytes by transferring Atg5−/− 
  fetal hematopoietic progenitor cells into lethally irradiated 
wild-type congenic hosts. We found that Atg5−/− lympho-
cytes exhibit multiple defects, including a reduced lympho-
cyte compartment, enhanced CD8+ T cell apoptosis, and an 
inability to undergo TCR-induced proliferation. Our results 
suggest that autophagy may play an essential role in T lym-
phocyte survival and function.
RESULTS AND DISCUSSION
Autophagy in mouse T lymphocytes
Recent reports suggest that thymocytes (19) and cultured 
human lymphocytes (21, 22) are capable of inducing  autophagy. 
To determine whether primary mouse T cells can form 
  autophagosomes, we took three approaches. First, to deter-
mine if T lymphocytes express autophagy machinery, thy-
mocytes and peripheral T cells were double sorted (>99% 
pure) and total RNA was isolated. Semiquantitative RT-
PCR was performed to detect the expression of Atg5, 
Beclin-1 (yeast Atg6), and LC3 (yeast Atg8) (Fig. 1 A). 
  Expression of these essential autophagy genes could be de-
tected in both thymocytes and mature T cells. In the thymus, 
Atg5, Beclin-1, and LC3 were most highly expressed in the 
double negative (DN) compartment. In the periphery, both 
CD4+ and CD8+ T cells expressed autophagy machinery. 
This expression was maintained after 2 d of in vitro stimula-
tion with anti-CD3.
Next, to determine if autophagosomes are present in 
T lymphocytes, we purifi  ed CD4+ and CD8+ T cells from 
the spleen and lymph nodes of naive mice (≥96% pure). Using 
transmission electron microscopy, we could identify charac-
teristic double membrane autophagosomes in both T cell 
Figure 1.  Atg5−/− thymocytes are reduced in number but develop 
normally. (A) Rag-2−/− DN thymocytes, sorted DP, CD4+ SP, CD8+ SP, and 
peripheral T cell subsets from C57BL/6 mice were analyzed for the expres-
sion of autophagy genes by semiquantitative RT-PCR. Both sorted CD4+ 
and CD8+ peripheral T cells were activated in vitro for 2 d with anti-CD3 
and subjected to RT-PCR analysis. (B) Transmission electron microscopy 
of peripheral T cells. Freshly isolated (F) and anti-CD3–activated (A) CD4+ 
and CD8+ T cells (n = 50) were cross sectioned and analyzed for the 
presence of autophagosomes (arrows). Activated cells were cultured in 
vitro for 2 d with anti-CD3. (C) T cell immunoblot for LC3. Purifi  ed T cells 
from C57BL/6 mice were either immediately lysed or amino acid starved 
in vitro for 4 h in a balanced salt solution, or stimulated with plate-bound 
anti-CD3 with or without hIL-2 (100 U/ml) for 16 h. The lysates were 
probed for LC3 processing. Actin serves as a loading control. (D) Total 
thymocyte number in Atg5−/− and wild-type chimeras. Circles and 
squares represent individual mice. P = 0.04. (E) FACS profi  le of Atg5−/− 
thymocytes. Total thymocytes were stained with anti-CD4 and anti-CD8. 
DN thymocytes were pregated on CD3−CD4−CD8− cells. (F) FACS analysis 
of thymocyte apoptosis. Thymocytes were stained with CD4, CD8, 7-AAD, 
and annexin V. Numbers indicate the percentage of cells in each region.JEM VOL. 204, January 22, 2007  27
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populations (Fig. 1 B). Quantifi  cation revealed that  10% 
of CD4+ and CD8+ T cell cross sections contained autopha-
gosomes (Fig. 1 B). We also analyzed autophagosome for-
mation in T cells purifi  ed after in vitro stimulation for 2 d 
with anti-CD3. Approximately 30% of activated cell cross 
sections contained autophagosomes (Fig. 1 B). However, 
the narrow depth of the section does not allow us to distin-
guish between an increase in the number of autophagosome 
per cell and an increase in the number of autophagosome-
positive cells.
Finally, we used immunoblotting for LC3 to detect 
  autophagy in T cells. LC3 undergoes regulated modifi  ca-
tions during the induction of autophagy, delivering a faster 
migrating processed band (termed LC3-II) to autophago-
somes (14). Although a small amount of LC3-II was present 
in freshly purifi  ed peripheral T cells, the ratio of LC3-II to 
LC3-I was increased after 4 h of amino acid starvation in a 
balanced salt solution and after anti-CD3–induced T cell 
activation with or without exogenous IL-2 (Fig. 1 C). Col-
lectively, these three results suggest that primary T lympho-
cytes form autophagosome and can regulate the induction 
of autophagy.
Thymocyte development in Atg5−/− chimeras
To determine the role of autophagy-related genes in T cell 
development and function, we reconstituted the immune 
system of adult mice with autophagy-defi  cient hematopoi-
etic precursors from mice lacking Atg5 (5). Atg5-defi  cient 
mice die within 24 h of birth because of their inability to 
survive brief periods of nutrient deprivation. We generated 
chimeric mice by transferring day 14 fetal liver cells from 
Atg5−/− and wild-type mice into lethally irradiated (950 rad) 
CD45.1+ congenic hosts. We analyzed the thymus of Atg5−/− 
and wild-type chimeras by fl  ow cytometry 6–10 wk after 
  reconstitution. In all chimeric mice, >99% of thymocytes 
recovered were CD45.2+ (unpublished data), indicating a 
complete reconstitution by donor-derived cells. When com-
pared with wild-type controls, Atg5−/− chimeras demon-
strated a 40–60% reduction in their total thymic cellularity 
(Fig. 1 D). Although the number of Atg5−/− thymocytes was 
reduced, the developmental profi  le of cells within the thy-
mus appeared normal (Fig. 1 E). Atg5−/− chimeras had nor-
mal percentages of CD4−CD8− DN, CD8+CD4+ double 
positive (DP), CD4+ single positive (SP), and CD8+ SP cells. 
Furthermore, the progressive subsets within the DN com-
partment as defi  ned by the expression of CD25 and CD44 
were comparable between Atg5−/− and wild-type control 
thymus. Atg5−/− thymocytes did not exhibit enhanced apop-
tosis as detected by annexin V and 7–aminoactinomycin 
D (7-AAD) staining (Fig. 1 F). Collectively, these results 
  demonstrate that Atg5-defi  cient thymocytes underwent full 
maturation without any obvious developmental blockade, 
suggesting that Atg5 is dispensable in thymocyte diff  erentiation. 
The reduced thymic cellularity may be caused by reduced 
lymphoid precursor activity in the absence of Atg5 (see 
following paragraph).
Reduced peripheral lymphocyte compartment 
in Atg5−/− chimeras
We examined the peripheral lymphocyte compartment of 
chimeric mice 6–10 wk after fetal liver reconstitution. 
CD45.2+ donor-derived CD4+ and CD8+ T lymphocytes 
were detected in the spleen of both Atg5−/− and wild-type 
chimeras (Fig. 2 A). Atg5−/− T cells expressed similar levels 
of TCR on their surface compared with control cells (Fig. 
2 A). However, the total numbers of Atg5−/− T and B lym-
phocytes in the spleen were only  10% of control chimeras 
(Fig. 2 B). In addition, the total number of cells obtained 
from the LNs of Atg5−/− chimeras was 10% of that in control 
mice (Atg5−/−: 0.83 + 0.8 × 106, n = 4; control: 8.2 + 6 × 
106,  n  = 3). In contrast, the number of Atg5−/− Gr-
1+CD11b+ neutrophils in the spleen was comparable to that 
of controls (Fig. 2 B), suggesting that Atg5−/− lymphoid 
  progenitors have a defective capacity to reconstitute the lym-
phoid compartment.
Interestingly, although the numbers of both Atg5−/− 
CD4+ and CD8+ T lymphocytes were dramatically reduced 
(Fig. 2 C), the reduction of Atg5−/− CD8+ T lymphocytes 
(5% of control cells) was more severe than that of Atg5−/− 
CD4+ T lymphocytes (10% of control cells) (Fig. 2 A and C). 
This was further indicated by the elevated CD4+ to CD8+ 
ratio of Atg5−/− T lymphocytes compared with that of 
Figure 2.  Defective peripheral lymphocyte compartment in 
Atg5−/− chimeras. (A) FACS profi  les of donor-derived CD4+ and CD8+ 
T cells in the spleens of Atg5−/− and wild-type chimeric mice 6–10 wk 
after reconstitution. All cells are pregated on CD45.2+ donor-derived 
cells. (B) The numbers of T cells, B cells, and neutrophils in the spleen of 
Atg5−/− and wild-type chimeras. The numbers are derived from multiplying 
the percentage of CD4+ and CD8+ T cells, B220+, or Gr-1+CD11b+ 
CD45.2+ cells by the total numbers of splenocytes. p values for comparison 
between Atg5−/− and wild-type chimeras are: T cells, P = 0.0267; 
B cells, P = 0.0001; PMN, P = 0.8785. (C) The numbers of CD4+ and CD8+ 
T lymphocytes in the spleen of Atg5−/− and wild-type chimeras. CD4+ 
T cells, P = 0.0678; CD8+ T cells, P = 0.002. (D) The CD4+ to CD8+ T cell 
ratio in Atg5−/− and wild-type chimeras. Shown are data from individual 
mice. P = 0.0163. All p values are derived from unpaired, two-tailed 
Student’s t test.28  ATG5 IN T LYMPHOCYTE SURVIVAL AND PROLIFERATION | Pua et al.
  control T cells (Fig. 2 D). Although the number of thymocytes 
in Atg5−/− chimeras is reduced, this dramatic and selective 
reduction in peripheral T lymphocytes suggests a role for auto-
phagy in mature T cells.
Selective survival defect in Atg5−/− CD8+ T cells
The process of autophagy is intimately linked to survival. 
Atg5 was fi  rst identifi  ed in a screen for yeast incapable of 
surviving nitrogen starvation (2). Given that CD8+ T cells 
exhibited a more severe reduction than CD4+ T cells in 
Atg5−/− chimeras, we examined whether Atg5 was required 
for mature CD8+ T cell survival in vivo. In freshly isolated 
splenocytes, <10% of wild-type but nearly 40% of Atg5−/− 
CD8+ T cells were annexin V+7-AAD− (Fig. 3 A), indicat-
ing that these cells had initiated apoptosis in vivo. Further-
more, the total apoptotic rate of Atg5−/− CD8+ T cells as 
indicated by annexin V+7-AAD− and annexin V+7-AAD+ 
staining was fi  ve to six times higher than that of control 
CD8+ T cells (Fig. 3, A and B). In contrast, the apoptotic 
rates of Atg5−/− CD4+ T lymphocytes and B220+ B lym-
phocytes were only slightly higher than those of control 
cells, whereas the apoptotic rate of Atg5−/− Gr-1+ neutro-
phils was similar to that of control cells (Fig. 3 B). Because 
a small fraction of host peripheral CD4+ and CD8+ T lym-
phocytes survived the lethal irradiation, we examined the 
apoptosis in these cells as an internal control. The apoptotic 
rates of CD4+ T lymphocytes from either wild-type and 
Atg5−/− donors or C57BL/6 congenic hosts were com-
parable (Fig. 3 C). However, the apoptotic rates of Atg5−/− 
CD8+ T cells were dramatically higher than those of either 
wild-type CD8+ or host long-lived CD8+ T cells (Fig. 3 C). 
This result suggests that Atg5, and perhaps the ability to in-
duce autophagy, is required for the survival of CD8+ T cells. 
Interestingly, we noticed that the apoptotic rates of CD4+ 
and CD8+ host T cells in Atg5−/− chimeras were also slightly 
higher than those of their counterparts in wild-type chime-
ras (Fig. 3 C). Whether this elevation is indirectly caused by 
the massive apoptosis of Atg5−/− CD8+ T cells remains to 
be determined.
Our results suggest that the survival defect seems to be 
specifi  c to peripheral T cells. Not only do Atg5−/− CD8+ SP 
thymocytes develop normally (Fig. 1 E), but Atg5−/− CD8+ 
SP thymocytes do not display an enhanced rate of apoptosis 
in vivo compared with wild-type controls (Fig. 1 F). How 
does Atg5 contribute to the survival of CD8+ T cells? One 
possibility is that peripheral CD8+ T cells depend on au-
tophagy for their survival. This is consistent with the expres-
sion of autophagy genes and presence of autophagosomes in 
these cells. This possibility implies that CD8+ T cells en-
counter either a nutrient shortage or cytokine deprivation or 
both after they exit the thymus. Growth factor deprivation–
induced autophagy has been shown to be critical for cell 
  survival (8). Given that CD4+ T cells also express autophagy 
machinery and form autophagosomes, it is interesting to see 
that CD4+ T cell survival is less dependent on Atg5 than 
CD8+ T cells.
Alternatively, Atg5 may regulate CD8+ T cell survival by 
interacting with antiapoptotic molecules. Published data have 
demonstrated a pattern of reciprocal relationships between 
autophagy and apoptosis. Both the inhibition of apoptosis 
can induce autophagy (19, 20, 23), and the inhibition of au-
tophagy can induce apoptosis (24). Molecular and functional 
studies have only begun to explore the complex relationship 
between autophagy and apoptosis. The mammalian Atg6 
  homologue, Beclin-1, was fi  rst identifi  ed as a Bcl-2–Bcl-xL 
interacting protein (17); however, the role of this interaction 
remains controversial. Bcl-2 has been shown to inhibit 
autophagosome formation in nutrient-starved yeast and hu-
man cancer cell lines (25), yet Bcl-2 expression in Bax−/−
Bak−/− mouse embryonic fi  broblasts enhances autophagy 
  after   etoposide treatment (19). In each of these in vitro studies, 
autophagy was required for the observed cellular death. 
However, the massive apoptosis we observe in Atg5−/− 
CD8+ T cells suggests that the capacity to induce autophagy 
in these cells is essential for their survival in vivo. Whether 
direct interactions between autophagy and apoptotic ma-
chinery contribute to the enhanced apoptosis in Atg5−/− 
CD8+ T cells will be an important area of future study.
Figure 3.  Selective survival defect in Atg5−/− CD8+ T cells. 
(A) FACS analysis of CD8+ T cell apoptosis. Donor-derived CD8+ T cells 
in Atg5−/− and wild-type chimeras were stained with 7-AAD and 
PE–  annexin V. Numbers indicate the percentage of cells in each region. 
(B). Ap  optotic rates of various cell populations in Atg5−/− and wild-type 
chimeras. Donor-derived cells (CD45.2+) were stained using the indicated 
lineage markers plus PE–annexin V and analyzed by FACS. CD8+ T cells, 
P = 0.0118; CD4+, P = 0.0544; B220+, P = 0.0826; Gr1+ cells, P = 0.6605. 
n = 3. (C) Apoptotic rates of donor-derived and host long-term surviving 
CD4+ and CD8+ T cells. p values for donor versus host T cells in Atg5−/− 
chimeras: CD4+ T cells, P = 0.72; CD8+ T cells, P = 0.004.JEM VOL. 204, January 22, 2007  29
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Impaired proliferation of Atg5−/− T lymphocytes 
to TCR stimulation
Next, we examined whether Atg5−/− T cells respond nor-
mally to TCR stimulation. Total splenocytes from Atg5−/− 
and wild-type chimeras were labeled with the fl  uorescent dye 
CFSE. After 3 d of anti-CD3 stimulation, 7-AAD− CD45.2+ 
donor-derived T cells were analyzed by fl  ow cytometry for 
proliferation as measured by CFSE dilution. Although 42% 
of wild-type CD4+ T cells proliferated in response to plate-
bound anti-CD3, only 9% of Atg5−/− CD4+ T cells prolifer-
ated (Fig. 4 A). In addition, the number of divisions within 
the dividing population was reduced in Atg5−/− T cells. 
Measured by the mean fl  uorescence intensity, the dilution 
of CFSE was greater in dividing wild-type T cells than in 
Atg5−/− cells. These proliferation defects could be rescued by 
neither the addition of an anti-CD28 costimulatory signal 
nor the proproliferative cytokine IL-2. When we bypassed 
membrane-proximal TCR/CD3 signaling by the use of 
PMA and ionomycin, 49% of Atg5−/− CD4+ T cells prolif-
erated compared with 69% of wild-type controls; however, 
the dilution of CFSE in dividing cells remained reduced 
in Atg5−/− T cells (Fig. 4 A). These results suggest that 
downstream mitogen-activated protein kinase activation and 
calcium mobilization can partially rescue the proliferation defect 
in Atg5−/− CD4+ T lymphocytes. Similar results were ob-
tained for Atg5−/− CD8+ T cells (unpublished data).
Although Atg5−/− T cells did not proliferate in response 
to CD3 stimulation, they did express normal levels of TCR 
(Fig. 2 A). After overnight stimulation, both wild-type and 
Atg5−/− T cells also expressed similar levels of the activation 
markers CD69 and CD25 (Fig. 4 B). This result suggests that 
Atg5−/− T cells can be activated through the TCR complex. 
Given that Atg5−/− CD8+ T cells displayed a survival defect, 
we determined whether enhanced apoptosis in activated 
Atg5−/− T cells might account for the reduced number of 
proliferating cells. At 4 and 24 h after stimulation, Atg5−/− 
CD4+ T cells did not display a dramatically enhanced rate 
of apoptosis compared with wild-type controls (Fig. 4 C). 
However, at 72 h we did observe an increased death in anti-
CD3–stimulated Atg5−/− CD4+ T cells. We observed the 
same result for Atg5−/− CD8+ T cells, although the baseline 
rate of cell death was dramatically enhanced in these cells. 
The absence of early death after TCR stimulation in T cells 
lacking the autophagy gene Atg5 suggests that the enhanced 
Figure 4.  Impaired proliferation of Atg5−/− T cells upon anti-CD3 
stimulation. (A) Proliferation of Atg5−/− and wild-type CD4+ T cells upon 
TCR stimulation. Splenocytes from control and Atg5−/− chimeras were 
labeled with CFSE and stimulated under the following conditions for 3 d: 
5 μg/ml of plate-bound anti-CD3, or plus 1 μg/ml plate-bound anti-CD28, 
or plus 100 U/ml of recombinant IL-2, or 10 ng/ml PMA plus 300 ng/ml 
of ionomycin. Shown are the percentage of cells with diluted CFSE 
  staining and the mean fl  uorescence intensity of the proliferating population. 
(B) Up-regulation of CD25 and CD69 on Atg5−/− and wild-type T cells 
after overnight stimulation with plate-bound anti-CD3. (C) Apoptosis rates 
of Atg5−/− and wild-type T cells after TCR stimulation. Total splenocytes 
were cultured either in media alone or with 5 μg/ml of plate bound 
anti-CD3 for the indicated times. Apoptosis was measured by annexin V 
staining. Data are representative of two experiments.30  ATG5 IN T LYMPHOCYTE SURVIVAL AND PROLIFERATION | Pua et al.
death observed at 72 h may result from the impaired activa-
tion of these cells. Although it is also possible that proliferat-
ing Atg5−/− T cells rely on autophagy to maintain their 
metabolism late in culture, the addition of the cell-permeable 
metabolic substrate methylpyruvate did not enhance our re-
covery of proliferating Atg5−/− T lymphocytes (unpublished 
data). It should be noted that at 72 h very few Atg5−/− CD8+ 
T cells were detected in the culture without anti-CD3 stimu-
lation and the apoptotic rate cannot be assessed.
Although autophagy has emerging roles in cellular sur-
vival and death, no specifi  c function in proliferation has been 
identifi  ed. Our results clearly demonstrate that in activated 
CD4+ and CD8+ T cells Atg5 is essential for T cell prolifera-
tion but not activation. It will be important to determine 
how the induction of autophagy is regulated during TCR 
stimulation. Although Atg5 is required for the induction of 
autophagy in mouse cells (1), it is also possible that Atg5 may 
serve an autophagy-independent role in T cell proliferation. 
Atg5 interacts with the death domain of the adaptor protein 
FADD (18). In HeLa cells, this interaction is required for 
IFN-γ–mediated autophagic cell death. FADD-defi  cient T cells 
display a defect in proliferation, with normal up-regulation of 
activation markers (26, 27). This similarity suggests that Atg5 
and FADD may act together, either in the autophagic process 
or independent of autophagy, to transduce signals important 
for T cell proliferation.
In summary, our results demonstrate that the autophagy 
gene Atg5 plays multiple roles in lymphocyte development 
and function. The reduced number of thymocytes and B 
lymphocytes suggests that Atg5 regulates lymphoid precursor 
activity. The reduced CD4+ and CD8+ T cell compartment 
in Atg5−/− chimeras is likely caused by both a lowered lym-
phoid precursor activity and an inability of these cells to un-
dergo homeostatic proliferation because during fetal liver 
reconstitutions, there is a transient period of lymphopenia in 
the host after irradiation. In addition, the selective apoptosis 
of Atg5−/− CD8+ T cells further contribute to the dramati-
cally reduced T cell compartment. Our results suggest that 
autophagy may play an essential role in T lymphocyte sur-
vival and proliferation.
MATERIALS AND METHODS
Animals. Atg5-defi  cient mice were generated and characterized previously 
(5). The mice were backcrossed for seven generations to C57BL/6. 6–8-wk-
old CD45.1 C57BL/6 mice were used as hosts for fetal liver transfers (The 
Jackson Laboratory). All mice were housed in a specifi  c pathogen-free faci-
lity and used according to protocols approved by the Duke University Insti-
tutional Animal Care and Use Committee.
RT-PCR. Thymocytes and peripheral T cells were isolated from C57BL/6 
mice by fl  uorescence-activated cell sorting (99% pure), and total RNA from 106 
cells was extracted with an RNeasy Mini kit (Qiagen). DN thymocytes were 
isolated from Rag-2−/− mice, and activated T cells were generated by culturing 
sorted peripheral T cells for 2 d with 5 μg/ml plate-bound anti-CD3. First-
strand cDNA was reverse transcribed with the iScript Reverse Transcriptase kit 
(Bio-Rad Laboratories). The expression of autophagy genes was determined 
by RT-PCR using the following primers: Atg5, 5′-G  A  C  A  A  A  G  A  T  G  T  G-
C  T  T  C  G  A  G  A  T  G  T  G  -3′ and 5′-G  T  A  G  C  T  C  A  G  A  T  G  C  T  C  G  C  T  C  A  G  -3′; 
Beclin-1, 5′-C  T  G  A  A  A  C  T  G  G  A  C  A  C  G  A  G  C  T  T  C  A  A  G  -3′ and 5′-C  C  A  G  A-
A  C  A  G  T  A  T  A  A  C  G  G  C  A  A  C  T  C  C  -3′; LC3a,5′-A  G  C  T  T  C  G  C  C  G  A  C  C  G  C-
T  G  T  A  A  G  -3′ and 5′-C  T  T  C  T  C  C  T  G  T  T  C  A  T  A  G  A  T  G  T  C  A  G  C  -3′; LC3b, 
5′-C  G  G  A  G  C  T  T  T  G  A  A  C  A  A  A  G  A  G  T  G  -3′ and 5′-T  C  T  C  T  C  A  C  T  C  T  C  G-
T  A  C  A  C  T  T  C  -3′; and Gapdh, 5′-C  C  T  G  G  A  G  A  A  A  C  C  T  G  C  C  A  A  G  T  A  T  -3′ 
and 5′-A  G  A  G  T  G  G  G  A  G  T  T  G  C  T  G  T  T  G  A  A  G  -3′.
Transmission electron microscopy. CD4+ and CD8+ T cells were 
purifi  ed from the spleen and lymph node of C57BL6 mice (≥96% pure) 
using EasySep negative bead selection (StemCell Technologies). Activated 
cells were stimulated for 2 d in vitro with 5 μg/ml soluble anti-CD3 before 
purifi   cation. Cell pellets were fi   xed in a 4% gluteraldehyde in 0.1 M 
sodium cacodylate buff  er overnight. The samples were rinsed in 0.1 M 
cacodylate buff  er containing 7.5% sucrose three times for 15 min each and 
fi  xed in 1% osmium in cacodylate buff  er for 1 h. After being washed three 
times in 0.11 M veronal acetate buff  er for 15 min each, the samples were 
incubated with 0.5% uranyl acetate in veronal acetate buff  er for 1 h at RT. 
Specimens were then dehydrated in an ascending series of ethanol (35%, 
70%, 95%, and 2 changes of 100%) for 10 min each, followed by two 
changes of propylene oxide for 5 min each. The samples were incubated 
with a 1:1 mixture of 100% resin and propylene oxide for 1 h, followed 
by  two changes of 100% resin, each for 30 min. Finally, the samples 
were embedded in resin and polymerized at 60°C overnight. Thick sec-
tions (0.5 μm) were cut and stained with toluidine blue for light micro-
scopy selection of the appropriate area for ultrathin sections. Thin sections 
(60–90 nm) were cut, mounted on copper grids, and then stained with 
uranyl acetate and lead citrate. Micrographs were taken with a Philips LS 
410 electron microscope.
Western blot. Total T cells were purifi  ed from the spleen and lymph 
node of C57BL6 mice (≥96% pure) using EasySep negative bead selection 
(StemCell Technologies). The cells were lysed in 50 mM Tris, pH 6.8, 
10% glycerol, 2% SDS, and 100 mM dithioreitol. LC3 was visualized using 
a rabbit polyclonal antibody (from Ron Kopito, Stanford University, 
  Stanford, CA), HRP-conjugated donkey anti–rabbit (Jackson Immuno-
Research Laboratories), and Femto chemiluminescent substrate (Pierce 
Chemical Co.).
Generation of chimeric mice. Fetuses were harvested from day 14 Atg5 
heterozygous pregnant female mice. DNA was isolated from 106 fetal liver 
cells using a DNeasy Tissue kit (Qiagen) for genotyping. The primers for the 
wild-type and deletion allele of the Atg5 gene were 5′-G  A  A  T  A  T  G  A  A  G  G-
C  A  C  A  C  C  C  C  T  G  A  A  A  T  G  -3′, 5′-A  C  A  A  C  G  T  C  G  A  G  C  A  C  A  G  C  T  G  C  G  C  A-
A  G  G  -3′, and 5′-G  T  A  C  T  G  C  A  T  A  A  T  G  G  T  T  T  A  A  C  T  C  T  T  G  C  -3′, and the 
PCRs were performed at 94°C for 30 s, 58°C for 30 s, and 72°C for 1 min 
for 30 cycles. 1–3 × 106 liver cells from wild-type and Atg5−/− fetuses were 
injected into lethally irradiated (950 rad) CD45.1 congenic hosts. Chimeric 
mice were analyzed 6–10 wk after reconstitution.
Flow cytometry analysis. Single cell suspensions of spleen and thymus 
were lysed of RBCs and incubated with FcR blocker (2.4G2; eBioscience). 
Cells were incubated with FITC, PE, PE/Cy5, APC, and biotinylated anti-
bodies followed by streptavidin-Alexa 594 for 30 min on ice. Antibodies 
used included anti-CD4, -CD8, -TCR-β, -B220, -Gr1, -Mac1, -CD25, 
-CD69, and -CD45.2 (eBioscience, BioLegend, and BD Biosciences). Dead 
cells were excluded by 7-AAD or propidium iodide staining (BD Bio-
sciences). Cell events were collected on a FACS STAR and analyzed using 
Cell Quest software (Becton Dickinson). Apoptotic cells were assayed by 
annexin V–PE kit and 7-AAD staining (BD Biosciences).
Cell proliferation. Splenocytes were labeled with CFSE (Molecular 
Probes) and stimulated with 5 μg/ml plate-bound anti-CD3 (2C11). In 
some cultures, plate-bound anti-CD28 (clone 37.51; BioLegend) or human 
recombinant IL-2 was added. Proliferation was assayed by fl  ow cytometry 
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